denosumab

GlycoNex reports positive results for denosumab biosimilar Phase I trial
Clinical Trials Arena
Tue, 08/20/24 - 10:31 am
GlycoNex
clinical trials
biosimilars
denosumab
osteoporosis
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Tue, 09/20/22 - 10:07 am
Novartis
Sandoz
clinical trials
biosimilarts
denosumab
osteoporosis
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Tue, 07/23/19 - 10:03 am
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Amgen's Xgeva Wins EU Approval
Yahoo/Zacks.com
Tue, 07/19/11 - 10:13 am
Amgen
Xgeva
Europe
GSK
denosumab
Novartis
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Motley Fool
Wed, 02/9/11 - 01:14 pm
Amgen
AMG785
denosumab
osteoporosis
Amgen Presents New XGEVA (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Yahoo/PR NewsWire
Sat, 12/11/10 - 11:41 am
Amgen
denosumab
Xgeva
breast cancer
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Sat, 11/20/10 - 12:22 pm
Amgen
Prolia
Xgeva
denosumab
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients
Bloomberg
Sat, 11/20/10 - 12:10 pm
Amgen
denosumab
cancer
Amgen Drug May Block Some Breast Cancer, Studies Hint
Bloomberg
Thu, 09/30/10 - 11:24 am
Amgen
breast cancer
denosumab
Amgen gets rapid FDA review for denosumab
Yahoo/AP
Mon, 07/19/10 - 09:30 am
Amgen
FDA
Prolia
denosumab
Amgen drug gets priority review for bone cancer
Marketwatch
Sun, 07/18/10 - 07:46 am
bone cancer
Amgen
FDA
denosumab
Prolia
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
Yahoo/PR NewsWire
Sat, 07/17/10 - 09:52 am
Amgen
denosumab
skeletal metastases
Amgen Gets FDA Approval and SonoSite Has a New Frontier
Motley Fool
Sat, 06/5/10 - 09:50 am
Amgen
denosumab
Prolia
SonoSite
ultrasound
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
PR-USA
Sun, 05/23/10 - 12:07 pm
Amgen
denosumab
zoledronic acid
Bone metastases
prostate cancer
Amgen’s Crop of Experimental Cancer Drugs Shows Initial Results
Bloomberg
Fri, 05/21/10 - 10:47 am
Amgen
cancer
pancreatic cancer
ovarian cancer
pipelines
denosumab
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Street Insider
Mon, 05/17/10 - 10:36 am
Amgen
BLA
FDA
denosumab
RANK Ligand inhibitor
Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients
Amgen, PR NewsWire
Sat, 05/15/10 - 11:51 am
Amgen
denosumab
Bone metastases

Pages